The Limited Times

Now you can see non-English news...

Covid-19 vaccine | Turkish Minister of Health says the delivery of Kexing vaccine will be postponed due to another confirmed diagnosis in Beijing

2020-12-27T22:34:53.201Z


Turkish Health Minister Fahrettin Koca stated that there was a customs-related case of new coronary pneumonia in Beijing, and 50 million doses of new coronary pneumonia vaccine were ordered from China Kexing. The first batch was originally scheduled for Monday (28


Instant International

Written by: Cao Jiajun

2020-12-28 06:23

Last update date: 2020-12-28 06:23

Turkish Health Minister Fahrettin Koca stated that there was a customs-related case of new coronary pneumonia in Beijing, and 50 million doses of new coronary pneumonia vaccines were ordered from China Kexing. The first batch was originally scheduled to arrive on Monday (28th). It will be postponed for one to two days.

Koca said on social media that there was a customs-related case of new coronary pneumonia in Beijing, which affected customs operations. As vaccines must complete border inspections before they can leave the country, the delivery of vaccines will also be delayed by one to two days.

The Hong Kong government also purchases vaccines developed by Sinovac in China.

(Profile picture)

The Hong Kong government also purchases vaccines developed by Sinovac ("Sinovac").

Turkish researchers said on December 24 that, according to the interim data of the local phase 3 clinical trial, the effective rate of Kexing vaccine was 91.25%.

Turkish Health Minister Koca (reuters)

[New Crown Vaccine] Turkey: Data show that the effective rate of China Kexing vaccine is 91.25%

9 COVID-19 patients killed in fire in intensive care department of a Turkish hospital

[New crown pneumonia] Turkey spreads the vaccinations "classification system", Ministry of Health denies

01News

New crown pneumonia new crown vaccine vaccine Turkey outbreak (new crown pneumonia)

Source: hk1

All news articles on 2020-12-27

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.